Toggle light / dark theme

Cortically-mediated muscle responses to balance perturbations increase with perturbation magnitude in older adults with and without Parkinson’s disease

New in eNeuro from Boebinger et al: Compared to young adults, older people with and without Parkinson’s disease have larger brain responses and muscle signals that hinder their balance recovery ability.

▶️


We lack a mechanistic understanding of how cortical contributions to balance control change in aging and Parkinson’s disease (PD). Balance is governed by brainstem circuits, with higher-order centers like the cortex or basal ganglia becoming engaged as challenge increases or balance health declines. We previously showed that parallel sensorimotor feedback loops engaging brainstem and cortical circuitry contribute to muscle activity for balance control in young adults (YAs). Here, we analyze data from male and female older adults (OAs) with and without PD, decomposing perturbation-evoked tibialis anterior and medial gastrocnemius muscle activity into hierarchical components based on latencies of feedback control loops. We found that balance-correcting muscle activity followed a stereotypical waveform of long-latency responses (LLRs): LLR1 began ∼120ms and LLR2 occurred ∼210ms, respectively, consistent with subcortical and cortical feedback latencies. Both LLRs increased with balance challenge and could be explained by center of mass kinematics. Perturbation-evoked antagonist muscle activity consisted of destabilizing and stabilizing components categorized based on whether they resist the kinematic errors that drive their activation. The destabilizing component occurred at ∼180ms and was negatively correlated with clinical measures of balance ability in the OA but not PD group. Exploratory comparisons showed OA and PD groups had larger LLR2s at lower challenge levels than YAs, consistent with greater cortical engagement during balance with aging. These findings demonstrate that a neuromechanical model can decompose perturbation-evoked muscle activity into hierarchical components related to clinical balance ability and identify mechanistic changes in the neural control of balance without direct brain measurements.

Significance Statement We show that reactive balance recovery in older adults with and without Parkinson’s disease can be decomposed into distinct components that reflect hierarchical brainstem, cortical, and basal ganglia feedback loops. Using a neuromechanical model of delayed task-level feedback control, we link these components to perturbation difficulty and clinical balance ability in older adults. This framework connects specific features of agonist and antagonist muscle activity to underlying neural control processes without requiring direct brain recordings. Our findings provide a mechanistic basis for age-and disease-related changes in balance control that can inform individualized assessment and future rehabilitation strategies.

Ultrastructural preservation of a whole large mammal brain with a protocol compatible with human physician-assisted death

Ultrastructural Preservation of a Whole Large Mammal Brain (bioRxiv, 2026) ⚠️ Preprint – not yet peer-reviewed.

A 2026 preprint builds on over a decade of brain preservation research, demonstrating that whole mammalian brains (pigs) can be preserved with remarkable structural fidelity under near–real-world, end-of-life conditions.

The study refines aldehyde-stabilized cryopreservation (ASC)—a technique previously recognized by the Brain Preservation Foundation. This method combines chemical fixation (aldehydes), cryoprotectants, and controlled cooling to prevent ice damage and preserve neural structure at the nanoscale. — What the study shows.

Whole pig brains preserved with intact cellular and synaptic architecture.

Preservation remains viable even with delayed postmortem intervals (~10 minutes)

Tissue remains perfusable and structurally stable after fixation.

Protocol moves toward clinically realistic implementation, not just lab conditions.

Scientists revive activity in frozen mouse brains for the first time

A familiar trope in science fiction is the cryopreserved time traveller, their body deep-frozen in suspended animation, then thawed and reawakened in another decade or century with all of their mental and physical capabilities intact.

Researchers attempting the cryogenic freezing and thawing of brain tissue from humans and other animals — mostly young vertebrates — have already shown that neuronal tissue can survive freezing on a cellular level and, after thawing, a functional one to some extent. But it has not been possible to fully restore the processes necessary for proper brain functioning — neuronal firing, cell metabolism and brain plasticity.

A team in Germany has now demonstrated a method for cryopreserving and thawing mouse brains that leaves some of this functionality intact. The study, published on 3 March in Proceedings of the National Academy of Sciences 3, details the authors’ use of a method called vitrification, which preserves tissue in a glass-like state, along with a thawing process that preserves living tissue.

“If brain function is an emergent property of its physical structure, how can we recover it from complete shutdown?” asks Alexander German, a neurologist at the University of Erlangen–Nuremberg in Germany and lead author of the study. The findings, he says, hint at the potential to one day protect the brain during disease or in the wake of severe injury, set up organ banks and even achieve whole-body cryopreservation of mammals.

Mrityunjay Kothari, who studies mechanical engineering at the University of New Hampshire in Durham, agrees that the study advances the state of the art in cryopreservation of brain tissue. “This kind of progress is what gradually turns science fiction into scientific possibility,” he says. However, he adds that applications such as the long-term banking of large organs or mammals remain far beyond the capabilities of the study.

Article Featured in Nature.


Mitochondrial capsule transplantation therapy shows potential for major diseases

Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy, achieving the safe and efficient transplantation of healthy mitochondria into cells and tissues for the first time. This new therapy can significantly alleviate symptoms of severe diseases such as Parkinson’s disease.

According to the study, published in the journal Cell, the therapy proposes a brand-new strategy in the field of regenerative medicine, shedding fresh light on intervention in refractory diseases caused by mitochondrial dysfunction, such as mitochondrial genetic diseases and neuron degenerative disorders.

Mitochondria are organelles that refer to specialized subunits with specific functions in cells. Mitochondria function like power plants in cells, continuously converting nutrients into energy for life activities. They are also the only organelles in human cells that possess their own genome.

The function of mRNA quality control in aging and age-related diseases

Aging is a complex biological process characterized by the gradual decline of physiological and molecular functions and increased susceptibility to age-associated diseases. Emerging evidence indicates the role of mRNA quality control mechanisms in the regulation of aging and longevity. This review focuses on the function of mRNA surveillance mechanisms, including nonsense-mediated mRNA decay (NMD), nonstop decay (NSD), and no-go decay (NGD), in aging and age-related diseases. We discuss the critical roles of these pathways in maintaining mRNA quality and preventing the accumulation of aberrant transcripts, which can contribute to aging and age-related disorders.

OMICmAge is a multiomic biological aging clock using electronic medical records

Using about 31,000 electronic medical records (EMRs), we developed the mortality biomarker EMRAge and used it to develop OMICmAge by integrating proteomic and metabolomic domains through epigenetic biomarker proxies. This scalable DNA-methylation measure quantifies biological aging, is associated with age-related incident and prevalent diseases, and its performance is comparable to or better than existing biomarkers at predicting mortality.

Age Reversal 2026: Why Getting Old Will Soon Be Optional

Is aging actually optional? According to this Harvard scientist, yes—and human trials start soon. He explains why aging is not inevitable but a medical condition we can now treat, sharing groundbreaking results from his lab including reversing blindness in animals and rejuvenating biological age by 75% in just six weeks.
The FDA has just approved the first human trials for age reversal, marking a turning point in medical history. This video covers the science, the economics, and a future where we spend our 80s and 90s as healthy as our 40s. This is the update you’ve been waiting for.
Credits to World Governments Summit & Dr David Sinclair

Please note that the links below are affiliate links, so we receive a small commission when you purchase a product through the links. Thank you for your support!
=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=
📒N1O1 10% OFF with Code : REVERSE 📒
Nitric Oxide Booster https://tinyurl.com/4krxe2tx.

🔶 Nuchido https://www.nuchido.com/REVERSEAGING FIRST ORDER 20% OFF code : REVERSEAGING20

🆕 Discount Coupon Code : REVERSE — ProHealth, RENUE, StemRegen, N1O1, NOVOS ☑

🔲 Activate Your Stem Cells Naturally — STEMREGEN 15% OFF https://tinyurl.com/StemRelease.

🌏ProHealth Longevity15% OFF, Subscription Upto 45% OFF Use Code “REVERSE”

Spontaneous aging-associated inflammation and genome instability in the immune system of turquoise killifish

Turquoise killifish are naturally short-lived vertebrates that serve as a model system for aging. The authors show that killifish exhibit age-related transformation in the immune system, which rapidly develops inflammation, genome instability and functional decline.

/* */